Preclinical News and Research

RSS
"Stem cells in drug discovery and development" workshop to be held during toxicology annual meeting

"Stem cells in drug discovery and development" workshop to be held during toxicology annual meeting

Enanta Pharmaceuticals nominates EDP-239 lead development candidate from NS5A HCV inhibitor program

Enanta Pharmaceuticals nominates EDP-239 lead development candidate from NS5A HCV inhibitor program

PINC trial to test anti-malarial drug in women with DCIS

PINC trial to test anti-malarial drug in women with DCIS

Lotus Pharmaceuticals adds five new prescription drugs to its products

Lotus Pharmaceuticals adds five new prescription drugs to its products

Geron highlights telomerase inhibitor's activity against cancer stem cells at AACR Special Conference

Geron highlights telomerase inhibitor's activity against cancer stem cells at AACR Special Conference

National Cancer Institute awards PDS Biotechnology $1.28M phase 2 SBIR contract

National Cancer Institute awards PDS Biotechnology $1.28M phase 2 SBIR contract

Rigel Pharmaceuticals reports net loss of $0.48 per share for fourth-quarter 2009

Rigel Pharmaceuticals reports net loss of $0.48 per share for fourth-quarter 2009

ArQule reports net loss of $36,136,000 for 2009

ArQule reports net loss of $36,136,000 for 2009

Synta Pharmaceuticals receives FDA approval for resuming elesclomol clinical development

Synta Pharmaceuticals receives FDA approval for resuming elesclomol clinical development

Sanquin Blood Supply Foundation, Netherlands Vaccine Institute launch AmpVacs project to develop influenza A vaccine

Sanquin Blood Supply Foundation, Netherlands Vaccine Institute launch AmpVacs project to develop influenza A vaccine

Pre-clinical study of Cardio3 BioSciences' proprietary C-Cath catheter announced

Pre-clinical study of Cardio3 BioSciences' proprietary C-Cath catheter announced

Inovio Biomedical's SynCon preventive DNA vaccine receives approval in Korea for Phase I clinical trial

Inovio Biomedical's SynCon preventive DNA vaccine receives approval in Korea for Phase I clinical trial

WuXi PharmaTech, JANSSEN division announce collaboration for preclinical services

WuXi PharmaTech, JANSSEN division announce collaboration for preclinical services

BioSante Pharmaceuticals announces receipt of two US patents directed to 2A/Furin technology

BioSante Pharmaceuticals announces receipt of two US patents directed to 2A/Furin technology

NovoStent receives CE Mark for SAMBA Stent and Delivery System for treatment of PAD

NovoStent receives CE Mark for SAMBA Stent and Delivery System for treatment of PAD

Quark Pharmaceuticals commences dosing in clinical study of QPI-1007 for NAION

Quark Pharmaceuticals commences dosing in clinical study of QPI-1007 for NAION

Isis Pharmaceuticals reports revenues of $32.3M for fourth-quarter 2009

Isis Pharmaceuticals reports revenues of $32.3M for fourth-quarter 2009

COMP issues positive opinion for Æterna Zentaris' perifosine orphan medicinal product designation

COMP issues positive opinion for Æterna Zentaris' perifosine orphan medicinal product designation

arGEN-X SIMPLE Antibody platform delivers multiple, diverse, ultra-potent functional antibodies

arGEN-X SIMPLE Antibody platform delivers multiple, diverse, ultra-potent functional antibodies

Eli Lilly, Covance announce key milestones of their first-year partnership

Eli Lilly, Covance announce key milestones of their first-year partnership

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.